Yu‐Wei Chen

1.6k total citations
73 papers, 1.1k citations indexed

About

Yu‐Wei Chen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Yu‐Wei Chen has authored 73 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Pulmonary and Respiratory Medicine, 24 papers in Oncology and 11 papers in Surgery. Recurrent topics in Yu‐Wei Chen's work include Prostate Cancer Diagnosis and Treatment (28 papers), Prostate Cancer Treatment and Research (24 papers) and Renal cell carcinoma treatment (16 papers). Yu‐Wei Chen is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (28 papers), Prostate Cancer Treatment and Research (24 papers) and Renal cell carcinoma treatment (16 papers). Yu‐Wei Chen collaborates with scholars based in United States, Taiwan and Canada. Yu‐Wei Chen's co-authors include Paul L. Nguyen, Vinayak Muralidhar, Brandon A. Mahal, Peter F. Orio, Neil E. Martin, Michelle D. Nezolosky, Clair J. Beard, Christopher J. Sweeney, Toni K. Choueiri and Felix Y. Feng and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Yu‐Wei Chen

69 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu‐Wei Chen United States 21 671 333 228 119 112 73 1.1k
Sharon S. Lum United States 22 301 0.4× 637 1.9× 392 1.7× 93 0.8× 95 0.8× 102 1.4k
Justin D. Blasberg United States 24 1.1k 1.6× 495 1.5× 429 1.9× 54 0.5× 147 1.3× 98 1.7k
Liesbet Van Eycken Belgium 17 272 0.4× 852 2.6× 165 0.7× 58 0.5× 87 0.8× 59 1.2k
Matthew A. Facktor United States 12 554 0.8× 687 2.1× 499 2.2× 27 0.2× 72 0.6× 21 1.5k
Stuart H. Packer United States 17 704 1.0× 441 1.3× 598 2.6× 68 0.6× 106 0.9× 35 1.3k
A. Brewster United Kingdom 16 499 0.7× 587 1.8× 414 1.8× 42 0.4× 76 0.7× 33 1.2k
Thomas P. Shakespeare Australia 19 690 1.0× 225 0.7× 286 1.3× 347 2.9× 21 0.2× 85 1.3k
Gary W. Chmielewski United States 20 1.1k 1.6× 253 0.8× 409 1.8× 262 2.2× 112 1.0× 47 1.4k
Mei‐Chin Hsieh United States 16 318 0.5× 476 1.4× 164 0.7× 18 0.2× 73 0.7× 64 832
David Pryor Australia 20 757 1.1× 352 1.1× 385 1.7× 271 2.3× 142 1.3× 85 1.4k

Countries citing papers authored by Yu‐Wei Chen

Since Specialization
Citations

This map shows the geographic impact of Yu‐Wei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Wei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Wei Chen more than expected).

Fields of papers citing papers by Yu‐Wei Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Wei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Wei Chen. The network helps show where Yu‐Wei Chen may publish in the future.

Co-authorship network of co-authors of Yu‐Wei Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Wei Chen. A scholar is included among the top collaborators of Yu‐Wei Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Wei Chen. Yu‐Wei Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yu‐Wei, et al.. (2025). Recent Developments in the Management of Renal Cell Cancer. JCO Oncology Practice. 21(10). 1385–1396.
2.
Chen, Yu‐Wei & Rana R. McKay. (2025). Mitigating the Risk of Skeletal Events in Metastatic Renal Cell Carcinoma. European Urology Focus. 11(3). 425–428.
3.
Ali, Muhammad, Renée Maria Saliby, Sharon Choi, et al.. (2024). Emerging Novel Functional Imaging and Immunotherapy in Renal Cell Carcinoma and Current Treatment Sequencing Strategies After Immunotherapy. American Society of Clinical Oncology Educational Book. 44(3). e438658–e438658. 3 indexed citations
4.
Park, Kyong Hwa, Yeul Hong Kim, K. Jason, et al.. (2024). Large-Scale Cancer Genomic Analysis Reveals Significant Disparities between Microsatellite Instability and Tumor Mutational Burden. Cancer Epidemiology Biomarkers & Prevention. 33(5). 712–720. 1 indexed citations
5.
Liu, Franklin, Dhruv Puri, Yu‐Wei Chen, et al.. (2024). Comparison of outcomes of radical and partial nephrectomy for sarcomatoid renal cell carcinoma: analysis of the national cancer database. World Journal of Urology. 42(1). 508–508.
6.
Kim, Jung Sun, Hwa Jung Sung, Yu‐Wei Chen, et al.. (2022). Polygenic Risk Scores Associated with Tumor Immune Infiltration in Common Cancers. Cancers. 14(22). 5571–5571. 3 indexed citations
7.
Chen, Yu‐Wei, Brian I. Rini, & Kathryn E. Beckermann. (2022). Emerging Targets in Clear Cell Renal Cell Carcinoma. Cancers. 14(19). 4843–4843. 16 indexed citations
8.
9.
Chen, Yu‐Wei, Mei‐Yi Wu, Tzu‐Ting Chen, et al.. (2022). Severe acute kidney disease is associated with worse kidney outcome among acute kidney injury patients. Scientific Reports. 12(1). 6492–6492. 8 indexed citations
10.
Dinh, Kathryn T., Ayal A. Aizer, Vinayak Muralidhar, et al.. (2018). Increased Vulnerability to Poorer Cancer-Specific Outcomes Following Recent Divorce. The American Journal of Medicine. 131(5). 517–523. 9 indexed citations
11.
Mahal, Brandon A., Yu‐Wei Chen, Roshan V. Sethi, et al.. (2017). Travel distance and stereotactic body radiotherapy for localized prostate cancer. Cancer. 124(6). 1141–1149. 22 indexed citations
12.
13.
14.
Pai, Reetesh K., et al.. (2016). Colorectal carcinomas with submucosal invasion (pT1): analysis of histopathological and molecular factors predicting lymph node metastasis. Modern Pathology. 30(1). 113–122. 33 indexed citations
15.
Muralidhar, Vinayak, Brent S. Rose, Yu‐Wei Chen, Michelle D. Nezolosky, & Paul L. Nguyen. (2016). Association Between Travel Distance and Choice of Treatment for Prostate Cancer: Does Geography Reduce Patient Choice?. International Journal of Radiation Oncology*Biology*Physics. 96(2). 313–317. 54 indexed citations
16.
Dinh, Kathryn T., Vinayak Muralidhar, Brandon A. Mahal, et al.. (2015). Occult High-risk Disease in Clinically Low-risk Prostate Cancer with ≥50% Positive Biopsy Cores: Should National Guidelines Stop Calling Them Low Risk?. Urology. 87. 125–132. 13 indexed citations
17.
Chen, Yu‐Wei, Brandon A. Mahal, Vinayak Muralidhar, et al.. (2015). Association Between Treatment at a High-Volume Facility and Improved Survival for Radiation-Treated Men With High-Risk Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 94(4). 683–690. 49 indexed citations
18.
Muralidhar, Vinayak, Kathryn T. Dinh, Brandon A. Mahal, et al.. (2015). Differential post-prostatectomy cancer-specific survival of occult T3 vs. clinical T3 prostate cancer: Implications for managing patients upstaged on prostate magnetic resonance imaging. Urologic Oncology Seminars and Original Investigations. 33(7). 330.e19–330.e25. 10 indexed citations
19.
Muralidhar, Vinayak, David R. Ziehr, Brandon A. Mahal, et al.. (2015). Association Between Older Age and Increasing Gleason Score. Clinical Genitourinary Cancer. 13(6). 525–530.e3. 18 indexed citations
20.
Chen, Yu‐Wei, Shih‐Hua Lin, Han‐Hsiang Chen, Fang‐Ju Sun, & Chih‐Jen Wu. (2010). Hyperkalemia Associated with Prolonged Magnesium Sulfate Administration in Preeclampsia. 24(1). 9–15. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sharon S. Lum Breakdown of academic impact, for papers by Justin D. Blasberg Breakdown of academic impact, for papers by Liesbet Van Eycken Breakdown of academic impact, for papers by Matthew A. Facktor Breakdown of academic impact, for papers by Stuart H. Packer Breakdown of academic impact, for papers by A. Brewster Breakdown of academic impact, for papers by Thomas P. Shakespeare Breakdown of academic impact, for papers by Gary W. Chmielewski Breakdown of academic impact, for papers by Mei‐Chin Hsieh Breakdown of academic impact, for papers by David Pryor
Rankless by CCL
2026